Max Scherzer Returns to the Blue Jays Rotation on His 42nd Birthday: The Start/Sit Call in Washington

Max Scherzer will be activated from the injured list to start Monday's series opener against the Nationals in Washington, manager John Schneider confirmed. It will be Scherzer's first major league appearance since June 10, it comes against one of his former organizations, and it falls on his 42nd birthday. The narrative writes itself. The fantasy decision is considerably less obvious.

Scherzer landed on the 15-day injured list in mid-June with back spasms, then hit a second delay after receiving three cortisone injections in his right thumb during the All-Star break. He cleared his final rehab hurdle with Triple-A Buffalo, throwing five hitless innings with seven strikeouts.

Reading the rehab line

Five hitless innings with seven punchouts is an encouraging final test, and it is the reason Toronto felt comfortable activating him rather than adding another rehab outing. But Triple-A results from a veteran on a rehab assignment are among the least predictive data points in baseball. Hitters at that level do not attack a Hall of Fame-caliber arsenal the way major league lineups do, and the purpose of the outing was to confirm health and build pitch count, not to establish form.

What the line does confirm is that the back is functional and that the thumb is not interfering with grip. Both of those were open questions two weeks ago. A pitcher who needed three injections in his throwing-hand thumb and who then executed a clean five-inning outing has answered the availability question, which is the first hurdle.

The second hurdle is stuff. Scherzer at 42, coming off a six-week layoff with two separate physical issues, is not the same pitcher who takes the mound in April at full build-up. Velocity in the first start back is worth watching closely, and so is pitch count, which will almost certainly be capped somewhere well short of a full workload.

The matchup

Washington is not an easy landing spot. The Nationals have run one of the more productive offenses in baseball this season, which is precisely why Boston was willing to pay a controllable left-hander to pry Curtis Mead out of that lineup. Mead's departure Saturday takes a meaningful bat out of the group, and that is a genuine mitigating factor for Monday's start, but the supporting cast remains dangerous.

Facing a strong offense in your first start off the injured list, on a limited pitch count, in a park that does not suppress offense, is the composite of nearly every risk factor a fantasy manager should be cataloging.

Fantasy fallout

In shallow redraft leagues, this is a sit. The pitch count alone caps the strikeout upside and makes a win unlikely, and the downside scenario, four innings and four runs against a good lineup, is a real possibility rather than a tail risk.

In deeper leagues where Scherzer occupies a rostered spot regardless, the calculus is different. You are not choosing whether to own him. You are choosing whether to absorb a volatile start in exchange for information, and the information has value: if the velocity is intact and he handles the lineup, he becomes a startable arm for the final two months of the season on a contending team.

In daily formats, Scherzer is a leverage play rather than a core play. Low ownership is guaranteed given the injury and the matchup, and the ceiling outcome, six innings of one-run ball with eight strikeouts, would return enormous value in a tournament. That is the only format where the risk profile is actually attractive.

The Verdexed model take

Our starting pitcher projections adjust for three factors that all point the same direction here: recent injured list time, expected pitch count on the first start back, and opponent lineup quality. Each of those is a negative input in isolation. Stacked together, they push our projected outcome for Monday well below Scherzer's season-long baseline.

The specific number our model cares about most is expected innings. A pitcher projected for four to five innings has a structurally capped strikeout distribution and a win probability that is heavily dependent on his bullpen, and that combination is why our system grades this start as a below-replacement play in season-long formats despite the pitcher's name.

Our medium-term projection is more favorable. If Scherzer comes through Monday healthy, the model's rest-of-season line for him improves substantially, because the durability discount currently applied to his projection is the largest single drag on it. One clean start removes most of that.

Betting angle

The market will price this start off reputation and off Toronto's team quality, which creates the possibility of an inflated number on the Blue Jays. Our model reads the Toronto side as slightly rich given the innings constraint and the bullpen exposure it creates. A team that needs its relievers to cover four or five innings against a good offense is a worse bet than its starting pitcher's name suggests.

Scherzer's strikeout prop is the more interesting market. Books frequently set first-start-back strikeout totals using season-long rates and then adjust for innings imperfectly, and the under has historically been the better side of that specific spot.

What's next

Watch the first inning velocity readings and the pitch count at the end of the fourth. Those two data points will tell you nearly everything about whether Scherzer is a rest-of-season fantasy asset or a name you can safely drop.

Toronto has real postseason stakes and no incentive to be careless with a 42-year-old arm, which means the leash Monday will be short by design. Judge the start on health, not on the box score.